Aspire Biopharma Holdings, Inc.
ASBPW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire Biopharma Holdings, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $145.4K in total; no superinvestor holds it.
Other share classesASBP
13F holders, Q4 2024
Institutional positions in Aspire Biopharma Holdings, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- −3 vs. Q3 2024
- Shares held
- 7.53M
- −7.01K (−0.1%) vs. Q3 2024
- Total value
- $378.3K
- +$35.7K (+10.4%) vs. Q3 2024
- New holders
- 1
- 0 more added
- Sold out
- 4
- 4 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ASBPW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $145.4K |
| Q1 2026 | 31 | $121.7K |
| Q4 2025 | 31 | $142.5K |
| Q3 2025 | 31 | $246.3K |
| Q2 2025 | 31 | $395.1K |
| Q1 2025 | 29 | $639.8K |
| Q4 2024 | 28 | $378.3K |
| Q3 2024 | 32 | $343.1K |
| Q2 2024 | 35 | $289.3K |
| Q1 2024 | 36 | $299.9K |
| Q4 2023 | 37 | $590.3K |
| Q3 2023 | 40 | $494.7K |
| Q2 2023 | 41 | $490.5K |
| Q1 2023 | 36 | $399.0K |
| Q4 2022 | 37 | $627.8K |
| Q3 2022 | 37 | $1.28M |
| Q2 2022 | 37 | $1.38M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Aspire Biopharma Holdings, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Highbridge Capital Management LLC | – | $80.8K | 0.00% | – | – |
| Saba Capital Management, L.P. | 983,603 | $40.6K | 0.00% | 00.0% | Unchanged |
| Linden Advisors LP | 899,999 | $36.2K | 0.00% | 00.0% | Unchanged |
| CNH Partners LLC | 647,633 | $30.8K | 0.00% | 00.0% | Unchanged |
| Periscope Capital Inc. | 554,200 | $26.3K | 0.02% | −2,100−0.4% | Reduced |
| Sculptor Capital LP | 500,000 | $20.6K | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 432,757 | $20.6K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 401,544 | $19.1K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 350,000 | $16.6K | 0.00% | 00.0% | Unchanged |
| Taconic Capital Advisors LP | 300,000 | $14.3K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 199,999 | $9.50K | 0.00% | 00.0% | Unchanged |
| Context Capital Management, LLC | 175,000 | $8.31K | 0.00% | 00.0% | Unchanged |
| Nomura Holdings Inc | 150,000 | $7.20K | 0.00% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 138,536 | $6.58K | 0.00% | 00.0% | Unchanged |
| Clear Street LLC | 138,466 | $6.58K | 0.00% | −100−0.1% | Reduced |
| LMR Partners LLP | 125,000 | $5.94K | 0.00% | +125,000 | New |
| Whitebox Advisors LLC | 118,750 | $5.64K | 0.00% | −6,250−5.0% | Reduced |
| Clear Street Derivatives LLC | 106,000 | $5.04K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | – | $4.75K | 0.00% | – | – |
| Caas Capital Management LP | 75,000 | $3.56K | 0.00% | 00.0% | Unchanged |
| Picton Mahoney Asset Management | 50,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 50,000 | $2.50K | 0.00% | 00.0% | Unchanged |
| Omers Administration Corp | 25,000 | $1.19K | 0.00% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,050,000 | $1.05K | 0.00% | 00.0% | Unchanged |
| Mint Tower Capital Management B.V. | 25,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Walleye Trading LLC | 13,076 | $621 | 0.00% | −13,114−50.1% | Reduced |
| Investors Research Corp | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Athos Capital Ltd | 21,383 | – | – | 00.0% | Unchanged |
| Walleye Capital LLC | 0 | $0 | 0.00% | −46,560−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −28,700−100.0% | Sold out |
| Meteora Capital, LLC | 0 | $0 | 0.00% | −21,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −14,183−100.0% | Sold out |
| PEAK6 Investments LLC | – | – | – | – | Not filed |